A pragmatic randomized phase III trial to assess the utility of adjusting chemotherapy dose & dosing schedule with the SALVage weekly dose-dense regimen in patients with poor prognostic OVARian cancers based on the tumor primary chemosensitivity and incomplete debulking surgery
Contact Person
Status
Pending
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
MaNGO
CEEGOG
ISGO
NCRI
DGOG